Pono Capital Two, Inc. (NASDAQ:PTWO – Get Free Report) major shareholder Co. Ltd. Zuu purchased 1,500 shares of the business’s stock in a transaction that occurred on Thursday, June 6th. The shares were purchased at an average price of $13.00 per share, for a total transaction of $19,500.00. Following the completion of the acquisition, the […]
Pono Capital Two, Inc. (NASDAQ:PTWO – Get Free Report) major shareholder Co. Ltd. Zuu purchased 1,500 shares of the business’s stock in a transaction that occurred on Thursday, June 6th. The shares were purchased at an average price of $13.00 per share, for a total transaction of $19,500.00. Following the completion of the acquisition, the […]
Pono Capital Two, Inc. (NASDAQ:PTWO – Get Free Report) major shareholder Co. Ltd. Zuu acquired 789 shares of the firm’s stock in a transaction on Thursday, May 23rd. The shares were bought at an average cost of $13.00 per share, with a total value of $10,257.00. Following the completion of the acquisition, the insider now […]
Pono Capital Two, Inc. (NASDAQ:PTWO – Get Free Report) major shareholder Co. Ltd. Zuu bought 789 shares of the stock in a transaction that occurred on Thursday, May 23rd. The shares were acquired at an average cost of $13.00 per share, with a total value of $10,257.00. Following the completion of the purchase, the insider […]
Pono Capital Two (NASDAQ:PTWO – Get Free Report) and Oncology Institute (NASDAQ:TOI – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, profitability, institutional ownership and valuation. Analyst Ratings This is a summary […]